Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Individual biological response of breast cancer tumours to proton irradiation in correlation with molecular and microenvironmental factors.

2019/35/B/NZ7/04342

Keywords:

protonotherapy radiobiological response breast cancer

Descriptors:

  • NZ5_7: Human disease treatment
  • NZ7_16: Other related subjects

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

woj.

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Julian Czesław Malicki 

Number of co-investigators in the project: 8

Call: OPUS 18 - announced on 2019-09-16

Amount awarded: 2 126 640 PLN

Project start date (Y-m-d): 2020-09-15

Project end date (Y-m-d): 2024-09-14

Project duration:: 48 months (the same as in the proposal)

Project status: Project completed

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (9)
  1. Primary cancer-associated fibroblasts exhibit high heterogeneity among breast cancer subtypes
    Authors:
    Oliwia Piwocka, Marika Musielak, Igor Piotrowski, Katarzyna Kulcenty, Beata Adamczyk, Magdalena Fundowicz, Wiktoria Maria Suchorska, Julian Malicki
    Academic press:
    Reports of Practical Oncology and Radiotherapy (rok: 2023, tom: 28(2), strony: 159-171), Wydawca: Via Medica
    Status:
    Published
    DOI:
    10.5603/RPOR.a2023.0026 - link to the publication
  2. Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
    Authors:
    D. M. Borowicz, K. N. Shipulin, G. V. Mytsin , A. Skrobała, P. Milecki, V. N. Gayevsky, V. Vondráček, J. Malicki.
    Academic press:
    Journal of Personalized Medicine (rok: 2021, tom: 11 (12), strony: 1311), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jpm11121311 - link to the publication
  3. Biological heterogeneity of primary cancer-associated fibroblast determines the breast cancer microenvironment.
    Authors:
    Musielak M, Piwócka O, Kulcenty K, Piotrowski I, Ampuła K, Adamczyk B, Fundowicz M, Kruszyna-Mochalska M, Suchorska WM, Malicki J.
    Academic press:
    American Journal of Cancer Research (rok: 2022, tom: 12(9), strony: 4411–4427), Wydawca: e-Century Publishing Corporation
    Status:
    Published
  4. Biological heterogeneity of primary cancer-associated fibroblast determines the breast cancer microenvironment.
    Authors:
    Musielak M, Piwócka O, Kulcenty K, Piotrowski I, Ampuła K, Adamczyk B, Fundowicz M, Kruszyna-Mochalska M, Suchorska WM, Malicki J.
    Academic press:
    American Journal of Cancer Research (rok: 2022, tom: 12(9), strony: 4411–4427), Wydawca: e-Century Publishing Corporation
    Status:
    Published
  5. Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
    Authors:
    D. M. Borowicz, K. N. Shipulin, G. V. Mytsin , A. Skrobała, P. Milecki, V. N. Gayevsky, V. Vondráček, J. Malicki.
    Academic press:
    Journal of Personalized Medicine (rok: 2021, tom: 11 (12), strony: 1311), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jpm11121311 - link to the publication
  6. Navigating challenges: optimising methods for primary cell culture isolation
    Authors:
    O. Piwocka, M. Musielak, K. Ampuła, I. Piotrowski, B. Adamczyk, M. Fundowicz, W. M. Suchorska, J. Malicki
    Academic press:
    Cancer Cell International (rok: 2024, tom: 24, strony: 45669), Wydawca: Spring Nature
    Status:
    Published
    DOI:
    10.1186/s12935-023-03190-4 - link to the publication
  7. Future Perspectives of Proton Therapy in Minimizing theToxicity of Breast Cancer Radiotherapy
    Authors:
    Musielak M, Suchorska W, Fundowicz M, Milecki P, Malicki J.
    Academic press:
    Journal of Personalized Medicine (rok: 2021, tom: 11(5), strony: 410), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jpm11050410 - link to the publication
  8. Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
    Authors:
    D. M. Borowicz, K. N. Shipulin, G. V. Mytsin , A. Skrobała, P. Milecki, V. N. Gayevsky, V. Vondráček, J. Malicki.
    Academic press:
    Journal of Personalized Medicine (rok: 2021, tom: 11 (12), strony: 1311), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jpm11121311 - link to the publication
  9. Future Perspectives of Proton Therapy in Minimizing theToxicity of Breast Cancer Radiotherapy
    Authors:
    Musielak M, Suchorska W, Fundowicz M, Milecki P, Malicki J.
    Academic press:
    Journal of Personalized Medicine (rok: 2021, tom: 11(5), strony: 410), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/jpm11050410 - link to the publication